arrow
S

Suguru Okami

bayer yakuhin ltd.
H指数:13
被引数:726

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease

新用户队列中,2型糖尿病合并慢性肾脏病患者使用SGLT2抑制剂或GLP-1受体激动剂的结局。

2025-06-040
OA
Cost of healthcare utilization associated with incident cardiovascular and renal disease in individuals with type 2 diabetes: A multinational, observational study across 12 countries
2022-04-1919
OAAI